Endotoxin-lnduced release of interleukin 6 and interleukin 1β in human blood is independent of tumor necrosis factor alpha

European Surgical Research

Volumn 28, Issue 1, 1996, Pages 55-62

  Vasilescu, C ^a   Berger, D ^a   Buttenschon K ^a   Seidelmann, M ^a   Beger, H G ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Endotoxins; Interleukin 1 ; Interleukin 6; Monoclonal antibodies; Tumor necrosis factor alpha; Whole blood stimulation

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION;

ANTIBODIES, MONOCLONAL; HUMAN; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; TUMOR NECROSIS FACTOR;

EID: 0029655605     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129440     Document Type: Article

References (23)

1. Wortei CH, von der Moehlen MA, van Deventer SJ, Sprung CL, Jastremski M, Lubbers MJ, Smith CR, Allen IE, ten Cate JW: Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: Relationship to endotoxin and cytokine levels. J Infect Dis 1992;166:1367-1374.
2. Tracey KJ, Beutler B, Lowry SF, Merrywcather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ. Zcntella A, Albert JD. Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-474.
3. Michic HR, Spriggs DR, Manogue KR. Sherman ML, Revhag A, O'Dwyer ST, Arthur K, Dinarello CA, Cerami A, Wolf TSM, Kufe DW, Wilmore DW: Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 1988:104:280-286.
4. Standiford TJ, Strieter RM: TNF and IL-1 in sepsis: Good cytokines gone bad. J Lab Clin Med 1992:120: 179-180.
5. Dinarello CA: The role of interleukin-1 in disease. N Engl J Med 1993; 328:106-113.
6. Okusawa S, Gelfand JA, Ikejinta T, Connolly RJ, Dinarello CA: Interleukin 1 induces a shock-like state in rabbits: Synergism with tumor necrosis and the effect of cyclooxygen-ase inhibition. J Clin Invest 1988: 81:1 162-1172.
7. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trul-lenque R, Fabra R, Heinrich PC: Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytcs. FEBS Lett 1989:242:237-239.
8. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF, Cerami A: Antibodies to cachectin/tumor necrosis factor reduce interleukin 1(5 and interleukin 6) appearance during lethal bacteremia. J Exp Med 1989:170 1627-1633.
9. Fisher CJ, Opal SM, Dhainaut JF. Stephens S, Zimmerman JL, Nightingdale P. Harris SJ. Schein RHM, Panacek EA, Vincent JL, Foulke GE, Warren EL, Garrard C, Park G, Bodmer MW, Cohen J, van der Linden C, Cross AS, Sadoff JC, The CB0006 Sepsis Syndrome Study Group: Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patienls with sepsis. Crit Care Med 1993:21:318-327.
10. Allen JN, Herzyk DJ, Allen ED, Wewers MD: Human whole blood interleukin-1-beta production: Kinetics. cell source, and comparison with TNF-alpha. J Lab Clin Med 1992:119:538-546.
11. Schindler R, Dinarello CA: Ultrafiltration to remove endotoxins and other cytokine-inducing materials from tissue culture media and parenteral fluids. Biotechniques 1990; 8:408-413.
12. Riches P, Gooding R, Millar BC, Rowbottom AW: Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. J Immunol Methods 1992;153:125-131.
13. Rothstein JL, Schreiber H: Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci USA 1993;85:607-611.
14. Sanchez-Cantu L, Rode HN, Yun TJ, Christou NV: Tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide. Arch Surg 1991;126:231-235.
15. Stricter RM, Remick DG, Ham JM, Coletti LM, Lynch JP, Kunkel SL: Tumor necrosis factor-alpha gene expression in human whole blood. J LeukocBiol 1990:47:366-370.
16. DeForge LE, Remick DG: Kinetics of TNF, IL-6 and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun 1991;174:18-24.
17. DeForge LE, Tracey DE, Kenney JS, Remick DG: Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopoly-saccharidc-stimulated human whole blood. Am J Pathol 1992; 140:1045-1054.
18. Elsaesser-Beile U, von Kleist S, Staehle W, Schurhammer-Fuhr-mann C, Mocnting JS, Gallati H: Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma. Cancer 1993:71: 231-236.
19. Nerad JL, Griffiths JK, van der Meer JW, Endres S. Poutsiaka DD, Keusch GT, Bennish M, Salam MA. Dinarello CA, Cannon JG: Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. J Leukoc Biol 1992;52:687-692.
20. Cerami A: Inflammatory cytokines. Clin Immunol Immunopathol 1992; 62:3-10.
21. Neilson IR, Ncilson KA, Yunis EJ, Rowe MI: Failure of tumor necrosis factor to produce hypotensive shock in the absence of endotoxin. Surgery 1989;106:439-443.
22. van der Poll T, van Deventer SJ, Hack CE, Wolbink GJ, Aarden LA, Bueller HR, ten Cate JW: Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood 1992;79:693-698.
23. Vasilcseu C, Berger D. Buttenschon K, Beger HG: Pattern of cytokine release in sepsis and postoperative acute phase reaction. Langenbecks Arch Chir 1994(Forumband):247-251.